Work

Tumour-infiltrating Lymphocytes and Interleukin-2 in Treatment of Advanced Cancer

Year: 1989

Type: article

Study design: Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(89)91609-7

Authors: RichardL. Kradin, DavidS. Lazarus, StevenM. Dubinett, Julie Gifford, Beverly Grove, JamesT. Kurnick, FredericI. Preffer, ClareE. Pinto, Elise Davidson, RonaldJ. Callahan, H.William Strauss

Institutions: Massachusetts General Hospital, Harvard University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: CHARACTERIZATION OF IN VIVO ACTIVATED HUMAN LYMPHOCYTES, CLINICAL USE OF T-LYMPHOCYTES FOR THERAPY OF LUNG CANCER

OpenAlex ID: W2140330161

FWCI: 13.5

Cites: 18

Cited by: 335

Related to: 10